Stock Price
130.00
Daily Change
1.00 0.78%
Monthly
-7.79%
Yearly
-46.78%
Q2 Forecast
127.56

CSL reported $62.95B in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alterity Therapeutics Limited AUD 30M 26M Apr/2026
Arca Biopharma USD 1.47B 537M Dec/2025
Bio Path USD 1000K 0 Sep/2025
Brainstorm Cell Therapeutics USD 8M 3M Sep/2025
Cara Therapeutics USD 366M 338M Sep/2025
CSL USD 55.89B 20.42B Dec/2025
Curis USD 3M 10M Apr/2026
Esperion Therapeutics USD 885M 351M Dec/2025
Infinity Pharmaceuticals USD 0 0 Apr/2026